GET DAILY SIGNALSNVE Corporation (NVEC) Falls -29.5% Over 30 Days After Q2 Results
Key Takeaways
- NVE Corporation (NVEC) declined roughly 29.5% over the past 30 days, from a closing price of $110.08 on September 30, 2026 to $77.58 on October 30, 2026.
- The selloff was triggered by fiscal second-quarter 2027 results reported after the close on October 21, 2026, which showed a 47% sequential decline in revenue and a 51% sequential drop in diluted earnings per share.
- Management attributed the weakness to a short-term inventory adjustment at a major medical device customer and a 95% year-over-year decline in defense product sales.
- Shares fell roughly 33% in a single session on October 22, 2026, prompting several securities law firms to announce investigations into the company's disclosures (no complaints have been filed).
- Despite the drop, first-half fiscal 2027 revenue rose 36% year over year, and the company declared a $1.00 quarterly cash dividend.
- Shares stabilized in the roughly $72–$82 range following the initial decline, off their late-October intraday low near $67.
Company Background and Positioning
NVE Corporation is a leading commercial developer of spintronics, a form of nanotechnology that uses electron spin rather than electron charge to acquire, store, and transmit information. Headquartered in Eden Prairie, Minnesota, and listed on Nasdaq, the company designs and manufactures high-performance spintronic sensors and couplers used across industrial, medical, automotive, and defense applications, and it licenses its magnetoresistive random-access memory (MRAM) technology. I follow NVEC for its consistently high margins, strong cash position, recurring dividend, and emerging exposure to robotics, power conversion, and the "artificial intelligence of things" (AIoT).
Stock Performance Over the Past 30 Days and Quarter
Over the last 30 days, NVEC fell approximately 29.5%, declining from a closing price of $110.08 on September 30, 2026 to $77.58 on October 30, 2026. Most of the move was concentrated in a single session on October 22, 2026, when shares dropped about 33% from $103.07 to $68.36 before partially recovering in the following sessions. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The broader quarterly trend tells a similar story. Shares closed at $114.82 on July 30, 2026, after a sharp rally that peaked near $134 in late July. Over the three months through October 30, the stock declined roughly 32%, reflecting a reversal of the enthusiasm that followed the company's strong first-quarter results and a more cautious reassessment after the second-quarter report.
Drivers Behind the Recent 30-Day Move
The primary catalyst was NVE's fiscal second-quarter 2027 earnings release on October 21, 2026. Total revenue declined 8% year over year to $5.83 million, product sales fell 9%, and net income decreased 4% to $3.17 million, or $0.65 per diluted share. On a sequential basis, revenue fell 47%, product sales declined 48%, and diluted EPS dropped 51%.
Management attributed the decline to a short-term inventory adjustment at one of its large medical device customers and a 95% decrease in defense product sales, while noting a 67% year-over-year increase in distributor sales. Executives also disclosed that part of the first quarter's strength reflected orders pulled forward from the second quarter. The sharp sequential deterioration and the revenue pull-forward disclosure prompted several securities law firms to announce investigations into potential securities law violations, adding to selling pressure. The company declared a $1.00 quarterly dividend, payable November 30, 2026 to shareholders of record on November 2, 2026.
Quarterly Context and Earnings Contrast
The quarter's trajectory was shaped by two opposing earnings reports. On July 22, 2026, NVE reported first-quarter fiscal 2027 results with revenue up 81% year over year to $11.03 million and net income up 79% to $6.39 million, or $1.32 per diluted share, driven by an 82% increase in product sales. The report sent shares up roughly 55% in a single session on July 23, 2026.
The enthusiasm faded through August and September as the company completed a leadership transition, appointing Peter G. Eames as president and CEO and expanding its board, while shares consolidated in the $97–$110 range. The second-quarter report then revealed that much of the first-quarter growth reflected pulled-forward orders, reversing the narrative and erasing the prior gains.
Key Factors to Monitor Going Forward
Investors will likely focus on whether the medical device and defense order softness proves temporary. Management has indicated it expects sales in those categories to recover in the current quarter and anticipates second-half fiscal 2027 revenue broadly consistent with the first half. The company's third-quarter results, expected in late January 2027, will provide the first test of that outlook.
Additional factors to monitor include the progress and outcome of the announced securities investigations, the pace of adoption of NVE's new wafer-level sensors and gear sensors for robotics and power conversion applications, the sustainability of the $1.00 quarterly dividend, and the company's effective tax rate, which management expects to remain in the 14%–16% range for the remainder of the fiscal year. From what I see, these elements will shape the near-term direction.
Exploring AI-Driven Trading Approaches
In my view, automated systems can offer useful perspectives when markets shift quickly. I reviewed Tickeron’s Trending AI Robots to see how various strategies are positioned right now. The page features a selection of top-performing bots that monitor thousands of tickers, highlighting those drawing attention based on recent results across different timeframes and approaches. It serves as a practical starting point for examining data-driven methods in changing conditions.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Harry Richardson — Algorithmic Trader & Strategy Developer Harry is an algorithmic trader specializing in impulse and breakout trading strategies across cryptocurrency and equity markets. With more than 10 years of experience in developing automated trading systems, he focuses on building structured algorithms designed to capture momentum while maintaining strict risk control. His approach combines quantitative analysis, real-market execution, and continuous performance monitoring. Vitalii prioritizes risk management, drawdown control, and strategy stability over short-term optimization, ensuring algorithms are adaptable to changing market conditions. He has developed and tested hundreds of automated strategies, working extensively with live trading environments, forward testing, and portfolio-level algorithm management. His work centers on transforming trading ideas into fully operational, scalable automated systems.
Aroon Indicator for NVEC shows an upward move is likely
NVEC's Aroon Indicator triggered a bullish signal on October 15, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 225 similar instances where the Aroon Indicator showed a similar pattern. In 189 of the 225 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 84%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where NVEC's RSI Indicator exited the oversold zone, 18 of 25 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 72%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 46 of 59 cases where NVEC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.
Following a +9.01% 3-day Advance, the price is estimated to grow further. Considering data from situations where NVEC advanced for three days, in 227 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 74%.
NVEC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NVEC as a result. In 58 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 61%.
The Moving Average Convergence Divergence Histogram (MACD) for NVEC turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 50 similar instances when the indicator turned negative. In 33 of the 50 cases the stock turned lower in the days that followed. This puts the odds of success at 66%.
NVEC moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for NVEC crossed bearishly below the 50-day moving average on October 20, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 19 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 53%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NVEC declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 34 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron PE Growth Rating for this company is 59 (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. NVEC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 71 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. NVEC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock better than average.
The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.194) is normal, around the industry mean (5.894). P/E Ratio (20.578) is within average values for comparable stocks, (16.337). NVEC's Projected Growth (PEG Ratio) (71.130) is very high in comparison to the industry average of (3.803). NVEC has a moderately high Dividend Yield (0.052) as compared to the industry average of (0.012). P/S Ratio (15.106) is also within normal values, averaging (46.468).
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a developer of devices using spintronics
Industry Semiconductors